MOUNTAIN VIEW, Calif. (AP) — The Food and Drug Administration has asked drugmaker MAP Pharmaceuticals Inc. to address issues tied to chemistry, manufacturing and controls before it can decide whether ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results